I have held RSH for awhile now,I do believe in the product and services they provide. However i see the real numbers are going to be when they enter the UK later on in the year and then US next year if not this year. I also believe that most of the users will be pre teens and teens, adults i cant see them using AS MUCH as the other demographic. I have have had asthma since i was 6 and i am 42 now, and my son is 21 and he still has it, we both know when we need the puffer etc. FDA approval was granted but not for BREAKTHROUGH DEVICE. This is my own opinion based on my families history and why our family has invested into it. Wish everyone luck in your future investments.
RSH Price at posting:
17.0¢ Sentiment: Buy Disclosure: Held
